• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗炎药物与常用抗生素联合治疗配方对病原菌的抗菌及抗生物膜作用

Antimicrobial and Antibiofilm Effects of Combinatorial Treatment Formulations of Anti-Inflammatory Drugs-Common Antibiotics against Pathogenic Bacteria.

作者信息

Tabatabaeifar Fatemehalsadat, Isaei Elham, Kalantar-Neyestanaki Davood, Morones-Ramírez José Rubén

机构信息

Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, UANL, Av. Universidad S/N, San Nicolás de los Garza 66455, Mexico.

Centro de Investigación en Biotecnología y Nanotecnología, Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Parque de Investigación e Innovación Tecnológica, Km. 10 Autopista al Aeropuerto Internacional Mariano Escobedo, Apodaca 66629, Mexico.

出版信息

Pharmaceutics. 2022 Dec 20;15(1):4. doi: 10.3390/pharmaceutics15010004.

DOI:10.3390/pharmaceutics15010004
PMID:36678634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9864814/
Abstract

With the spread of multi-drug-resistant (MDR) bacteria and the lack of effective antibiotics to treat them, developing new therapeutic methods and strategies is essential. In this study, we evaluated the antibacterial and antibiofilm activity of different formulations composed of ibuprofen (IBP), acetylsalicylic acid (ASA), and dexamethasone sodium phosphate (DXP) in combination with ciprofloxacin (CIP), gentamicin (GEN), cefepime (FEP), imipenem (IPM), and meropenem (MEM) on clinical isolates of () and () as well as the transcription levels of biofilm-associated genes in the presence of sub-MICs of IBP, ASA, and DXP. The minimal inhibitory concentrations (MICs), minimal biofilm inhibitory concentrations (MBICs), and minimum biofilm eradication concentrations (MBECs) of CIP, GEN, FEP, IPM, and MEM with/without sub-MICs of IBP (200 µg/mL), ASA (200 µg/mL), and DXP (500 µg/mL) for the clinical isolates were determined by the microbroth dilution method. Quantitative real-time-PCR (qPCR) was used to determine the expression levels of biofilm-related genes, including in and in at sub-MICs of IBP, ASA, and DXP. All isolates were methicillin-resistant (MRSA), and all were resistant to carbapenems. IBP decreased the levels of MIC, MBIC, and MBEC for all antibiotic agents in both clinical isolates, except for FEP among isolates. In MRSA isolates, ASA decreased the MICs of GEN, FEP, and IPM and the MBICs of IPM and MEM. In , ASA decreased the MICs of FEP, IPM, and MEM, the MBICs of FEP and MEM, and the MBEC of FEP. DXP increased the MICs of CIP, GEN, and FEP, and the MBICs of CIP, GEN, and FEP among both clinical isolates. The MBECs of CIP and FEP for MRSA isolates and the MBECs of CIP, GEN, and MEM among isolates increased in the presence of DXP. IBP and ASA at 200 µg/mL significantly decreased the transcription level of in , and IBP significantly decreased the transcription level of in . DXP at 500 µg/mL significantly increased the expression levels of and genes in and isolates, respectively. Our findings showed that the formulations containing ASA and IBP have significant effects on decreasing the MIC, MBIC, and MBEC levels of some antibiotics and can down-regulate the expression of biofilm-related genes such as and . Therefore, NSAIDs represent appropriate candidates for the design of new antibacterial and antibiofilm therapeutic formulations.

摘要

随着多重耐药(MDR)细菌的传播以及缺乏有效的抗生素来治疗它们,开发新的治疗方法和策略至关重要。在本研究中,我们评估了由布洛芬(IBP)、乙酰水杨酸(ASA)和地塞米松磷酸钠(DXP)与环丙沙星(CIP)、庆大霉素(GEN)、头孢吡肟(FEP)、亚胺培南(IPM)和美罗培南(MEM)组成的不同制剂对()和()临床分离株的抗菌和抗生物膜活性,以及在亚抑菌浓度的IBP、ASA和DXP存在下生物膜相关基因的转录水平。通过微量肉汤稀释法测定了CIP、GEN、FEP、IPM和MEM在有/无亚抑菌浓度的IBP(200μg/mL)、ASA(200μg/mL)和DXP(500μg/mL)情况下对临床分离株的最低抑菌浓度(MIC)、最低生物膜抑制浓度(MBIC)和最低生物膜根除浓度(MBEC)。采用定量实时聚合酶链反应(qPCR)来测定在亚抑菌浓度的IBP、ASA和DXP情况下生物膜相关基因的表达水平,包括在()中的()和在()中的()。所有()分离株均为耐甲氧西林金黄色葡萄球菌(MRSA),所有()均对碳青霉烯类耐药。在两种临床分离株中,IBP降低了所有抗生素的MIC、MBIC和MBEC水平,但在()分离株中FEP除外。在MRSA分离株中,ASA降低了GEN、FEP和IPM的MIC以及IPM和MEM的MBIC。在()中,ASA降低了FEP、IPM和MEM的MIC、FEP和MEM的MBIC以及FEP的MBEC。DXP增加了两种临床分离株中CIP、GEN和FEP的MIC以及CIP、GEN和FEP的MBIC。在DXP存在的情况下,MRSA分离株中CIP和FEP的MBEC以及()分离株中CIP、GEN和MEM的MBEC增加。200μg/mL的IBP和ASA显著降低了()中()的转录水平,IBP显著降低了()中()的转录水平。500μg/mL的DXP分别显著增加了()和()分离株中()和()基因的表达水平。我们的研究结果表明,含有ASA和IBP的制剂对降低某些抗生素的MIC、MBIC和MBEC水平有显著作用,并且可以下调生物膜相关基因如()和()的表达。因此,非甾体抗炎药是设计新型抗菌和抗生物膜治疗制剂的合适候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/f69ea4ea0ae5/pharmaceutics-15-00004-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/0c7511dab812/pharmaceutics-15-00004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/dddb908eecb9/pharmaceutics-15-00004-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/9778eb5679d7/pharmaceutics-15-00004-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/55cdfaca13c6/pharmaceutics-15-00004-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/6e2306a8247b/pharmaceutics-15-00004-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/f69ea4ea0ae5/pharmaceutics-15-00004-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/0c7511dab812/pharmaceutics-15-00004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/dddb908eecb9/pharmaceutics-15-00004-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/9778eb5679d7/pharmaceutics-15-00004-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/55cdfaca13c6/pharmaceutics-15-00004-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/6e2306a8247b/pharmaceutics-15-00004-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f3/9864814/f69ea4ea0ae5/pharmaceutics-15-00004-g006.jpg

相似文献

1
Antimicrobial and Antibiofilm Effects of Combinatorial Treatment Formulations of Anti-Inflammatory Drugs-Common Antibiotics against Pathogenic Bacteria.抗炎药物与常用抗生素联合治疗配方对病原菌的抗菌及抗生物膜作用
Pharmaceutics. 2022 Dec 20;15(1):4. doi: 10.3390/pharmaceutics15010004.
2
Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms.联合抗菌治疗:抗葡萄球菌药物苯唑西林与抗菌肽乳链菌肽对表皮葡萄球菌临床分离株和金黄色葡萄球菌生物膜的体外协同作用。
Ann Clin Microbiol Antimicrob. 2024 Jan 20;23(1):7. doi: 10.1186/s12941-024-00667-6.
3
Antibiofilm effect of melittin alone and in combination with conventional antibiotics toward strong biofilm of MDR-MRSA and -.蜂毒素单独及与传统抗生素联合对多重耐药耐甲氧西林金黄色葡萄球菌强生物膜的抗生物膜作用及……(原文结尾不完整)
Front Microbiol. 2023 Feb 20;14:1030401. doi: 10.3389/fmicb.2023.1030401. eCollection 2023.
4
[Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].金黄色葡萄球菌生物被膜对万古霉素、庆大霉素和利福平的敏感性
Epidemiol Mikrobiol Imunol. 2010 Apr;59(2):80-7.
5
A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and -VRSA.让无效抗生素重新用于治疗的希望:研究蜂毒肽单独以及与青霉素和苯唑西林联合使用对多重耐药性耐甲氧西林金黄色葡萄球菌(MRSA)和耐万古霉素金黄色葡萄球菌(VRSA)的抗生物膜潜力。
Front Microbiol. 2024 Feb 1;14:1269392. doi: 10.3389/fmicb.2023.1269392. eCollection 2023.
6
Reducing Effect of Cloxacillin on Minimum Inhibitory Concentrations to Imipenem, Meropenem, Ceftazidime, and Cefepime in Carbapenem-resistant Isolates.耐碳青霉烯类抗生素分离株中氯唑西林对亚胺培南、美罗培南、头孢他啶和头孢吡肟最低抑菌浓度的降低作用。
Yale J Biol Med. 2020 Mar 27;93(1):29-34. eCollection 2020 Mar.
7
Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.纳米氧化锌对金黄色葡萄球菌分离株耐甲氧西林、万古霉素、利奈唑胺和生物膜形成的影响。
Ann Clin Microbiol Antimicrob. 2021 Aug 21;20(1):54. doi: 10.1186/s12941-021-00459-2.
8
Antimicrobial and Anti-Biofilm Activities of Citrus sinensis and Moringa oleifera Against the Pathogenic Pseudomonas aeruginosa and Staphylococcus aureus.橙子和辣木对致病性铜绿假单胞菌和金黄色葡萄球菌的抗菌及抗生物膜活性
Cureus. 2020 Dec 28;12(12):e12337. doi: 10.7759/cureus.12337.
9
Potential natural antimicrobial and antibiofilm properties of Piper betle L. against Staphylococcus pseudintermedius and methicillin-resistant strains.菝葜对中间葡萄球菌和耐甲氧西林金黄色葡萄球菌潜在的天然抗菌和抗生物膜特性。
J Ethnopharmacol. 2023 Dec 5;317:116820. doi: 10.1016/j.jep.2023.116820. Epub 2023 Jun 25.
10
In vitro and in vivo antibiofilm activity of the synthetic antimicrobial peptide WLBU2 against multiple drug resistant Pseudomonas aeruginosa strains.体外和体内抗多药耐药铜绿假单胞菌合成抗菌肽 WLBU2 的生物膜活性。
BMC Microbiol. 2023 May 15;23(1):131. doi: 10.1186/s12866-023-02886-x.

引用本文的文献

1
Anti-inflammatory drugs as potential antimicrobial agents: a review.抗炎药物作为潜在抗菌剂的综述
Front Pharmacol. 2025 Apr 8;16:1557333. doi: 10.3389/fphar.2025.1557333. eCollection 2025.
2
Sodium ibuprofenate: antibacterial activities and potential β-lactamase inhibition in critical Gram-negative bacteria.异丁苯丙酸二钠:对关键革兰氏阴性菌的抗菌活性及潜在的β-内酰胺酶抑制作用
Future Microbiol. 2025 Apr;20(5):395-407. doi: 10.1080/17460913.2025.2475639. Epub 2025 Mar 9.
3
Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning.

本文引用的文献

1
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa.针对新出现的多重耐药铜绿假单胞菌的治疗策略
Infect Dis Ther. 2022 Apr;11(2):661-682. doi: 10.1007/s40121-022-00591-2. Epub 2022 Feb 12.
2
Antimicrobial Activity of Non-steroidal Anti-inflammatory Drugs on Biofilm: Current Evidence and Potential for Drug Repurposing.非甾体抗炎药对生物膜的抗菌活性:当前证据及药物再利用潜力
Front Microbiol. 2021 Jul 27;12:707629. doi: 10.3389/fmicb.2021.707629. eCollection 2021.
3
Antimicrobial resistance and virulence characteristics in ERIC-PCR typed biofilm forming isolates of P. aeruginosa.
通过药物重新定位改善多重耐药菌引起的细菌感染的治疗。
Front Pharmacol. 2024 Jun 7;15:1397602. doi: 10.3389/fphar.2024.1397602. eCollection 2024.
产绿脓菌素的铜绿假单胞菌 ERIC-PCR 分型生物膜形成分离株的耐药性和毒力特征。
Microb Pathog. 2021 Sep;158:105042. doi: 10.1016/j.micpath.2021.105042. Epub 2021 Jun 11.
4
Antibiotic Tolerance of Biofilm in Periprosthetic Joint Infections and Antibiofilm Strategies.人工关节感染中生物膜的抗生素耐受性及抗生物膜策略
Antibiotics (Basel). 2020 Aug 27;9(9):547. doi: 10.3390/antibiotics9090547.
5
Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus.双氯芬酸减轻多重耐药金黄色葡萄球菌的毒力。
Arch Microbiol. 2020 Dec;202(10):2751-2760. doi: 10.1007/s00203-020-01992-y. Epub 2020 Jul 31.
6
Characterization of different alginate lyases for dissolving Pseudomonas aeruginosa biofilms.不同海藻酸盐裂解酶溶解铜绿假单胞菌生物膜的特性研究。
Sci Rep. 2020 Jun 10;10(1):9390. doi: 10.1038/s41598-020-66293-2.
7
Reducing Effect of Cloxacillin on Minimum Inhibitory Concentrations to Imipenem, Meropenem, Ceftazidime, and Cefepime in Carbapenem-resistant Isolates.耐碳青霉烯类抗生素分离株中氯唑西林对亚胺培南、美罗培南、头孢他啶和头孢吡肟最低抑菌浓度的降低作用。
Yale J Biol Med. 2020 Mar 27;93(1):29-34. eCollection 2020 Mar.
8
Bacterial Biofilm and its Role in the Pathogenesis of Disease.细菌生物膜及其在疾病发病机制中的作用
Antibiotics (Basel). 2020 Feb 3;9(2):59. doi: 10.3390/antibiotics9020059.
9
Ibuprofen-mediated potential inhibition of biofilm development and quorum sensing in Pseudomonas aeruginosa.布洛芬对铜绿假单胞菌生物膜形成和群体感应的潜在抑制作用。
Life Sci. 2019 Nov 15;237:116947. doi: 10.1016/j.lfs.2019.116947. Epub 2019 Oct 9.
10
MBEC Versus MBIC: the Lack of Differentiation between Biofilm Reducing and Inhibitory Effects as a Current Problem in Biofilm Methodology.最低生物被膜消除浓度(MBEC)与最低生物被膜抑制浓度(MBIC):生物被膜减少和抑制作用之间缺乏区分作为生物被膜方法学中的当前问题
Biol Proced Online. 2019 Sep 13;21:18. doi: 10.1186/s12575-019-0106-0. eCollection 2019.